Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder [Phase 2, Phase 3]

View source ↗

Summary

This is a completed Phase 2/3 trial evaluating the efficacy and safety of tamsulosin in children with neurogenic bladder, with results posted in September 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder

Drugs mentioned

• Tamsulosin (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Bladder, Neurogenic | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-09-12